BAFF and APRIL induce inflammatory activation of THP-1 cells through interaction with their conventional receptors and activation of MAPK and NF-κB

Inflammation Research

Volumn 60, Issue 9, 2011, Pages 807-815

  Lee, Sang Min ^a   Kim, Eun Ju ^a   Suk, Kyoungho ^a   Lee, Won Ha ^a  

^a Kyungpook National University   (South Korea)

Author keywords

APRIL; BAFF; Inflammation; MAPK; NF B

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; APRIL PROTEIN; B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; B CELL MATURATION ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; GELATINASE A; GELATINASE B; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SH2; PROTEIN TYROSINE PHOSPHATASE SHP 1; RECOMBINANT PROTEIN; SALAZOSULFAPYRIDINE; SMALL INTERFERING RNA; STAT PROTEIN; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRANSCRIPTION FACTOR RELA; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

ARTICLE; BINDING SITE; CELL ACTIVATION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

EID: 85027938459     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-011-0336-3     Document Type: Article

References (41)

1. F Mackay P Schneider P Rennert J Browning 2003 BAFF and APRIL: a tutorial on B cell survival Annu Rev Immunol 21 231 264 12427767 10.1146/annurev. immunol.21.120601.141152 1:CAS:528:DC%2BD3sXjtF2isr0%3D (Pubitemid 37174532)
2. L Gorelik K Gilbride M Dobles SL Kalled D Zandman ML Scott 2003 Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells J Exp Med 198 937 945 12975458 10.1084/jem.20030789 1:CAS:528:DC%2BD3sXnsV2ntLY%3D (Pubitemid 37152930)
3. LG Ng CR Mackay F Mackay 2005 The BAFF/APRIL system: life beyond B lymphocytes Mol Immunol 42 763 772 15829264 10.1016/j.molimm.2004.06.041 1:CAS:528:DC%2BD2MXjtFOmtb8%3D (Pubitemid 40489025)
4. SR Dillon JA Gross SM Ansell AJ Novak 2006 An APRIL to remember: novel TNF ligands as therapeutic targets Nat Rev Drug Discov 5 235 246 16474316 10.1038/nrd1982 1:CAS:528:DC%2BD28XhvFOmu7c%3D (Pubitemid 43336036)
5. MV Jonsson P Szodoray S Jellestad R Jonsson K Skarstein 2005 Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome J Clin Immunol 25 189 201 15981083 10.1007/s10875-005-4091-5 1:CAS:528:DC%2BD2MXnsVehtLo%3D (Pubitemid 40884044)
6. JO Pers C Daridon V Devauchelle S Jousse A Saraux C Jamin, et al. 2005 BAFF overexpression is associated with autoantibody production in autoimmune diseases Ann NY Acad Sci 1050 34 39 16014518 10.1196/annals.1313.004 1:CAS:528:DC%2BD2MXhtVWgtrzN (Pubitemid 41129420)
7. TM Seyler YW Park S Takemura RJ Bram PJ Kurtin JJ Goronzy, et al. 2005 BLyS and APRIL in rheumatoid arthritis J Clin Invest 115 3083 3092 16239971 10.1172/JCI25265 1:CAS:528:DC%2BD2MXhtF2kt73E (Pubitemid 41567573)
8. W Stohl S Metyas SM Tan GS Cheema B Oamar D Xu, et al. 2003 B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations Arthritis Rheum 48 3475 3486 14673998 10.1002/art.11354 (Pubitemid 37531913)
9. P Schneider 2005 The role of APRIL and BAFF in lymphocyte activation Curr Opin Immunol 17 282 289 15886118 10.1016/j.coi.2005.04.005 1:CAS:528: DC%2BD2MXjvFeksLs%3D (Pubitemid 40692663)
10. ST Jeon WJ Kim SM Lee MY Lee SB Park SH Lee, et al. 2010 Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells Immunol Cell Biol 88 148 156 19841639 10.1038/icb.2009.75 1:CAS:528:DC%2BC3cXitFehtbo%3D
11. SM Lee ST Jeon WJ Kim K Suk WH Lee 2010 Macrophages express membrane bound form of APRIL that can generate immunomodulatory signals Immunology 131 350 356 20518823 10.1111/j.1365-2567.2010.03306.x 1:CAS:528:DC%2BC3cXhtlGlsb7N
12. SM Lee WJ Kim K Suk WH Lee 2010 Cell to cell interaction can activate membrane-bound APRIL which are expressed on inflammatory macrophages Immune Netw 10 173 180 21165246 10.4110/in.2010.10.5.173 1:CAS:528:DC%2BC3cXhvFCksrc%3D
13. K Izawa J Kitaura Y Yamanishi T Matsuoka A Kaitani M Sugiuchi, et al. 2009 An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cells J Immunol 183 925 936 19561101 10.4049/jimmunol.0900552 1:CAS:528:DC%2BD1MXotFWgtLY%3D
14. SM Lee YP Nam K Suk H LW 2010 IREM-1 inhibits BAFF-mediated inflammatory regulation of THP-1 cells through modulation of the activities of ERK Clin Exp Immunol 161 504 511 20646006 10.1111/j.1365-2249.2010.04211.x 1:CAS:528:DC%2BC3cXhtFOku7%2FP
15. H Xi KJ Katschke Jr KY Helmy PA Wark N Kljavin H Clark, et al. 2010 Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1 J Exp Med 207 7-16 S1 S5
16. ZZ Chong K Maiese 2007 The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury Histol Histopathol 22 1251 1267 17647198 1:CAS:528:DC%2BD2sXhtlaks7bE (Pubitemid 47470319)
17. U Lorenz 2009 SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels Immunol Rev 228 342 359 19290938 10.1111/j.1600-065X.2008.00760.x
18. WH Lee SH Kim Y Lee BB Lee B Kwon H Song, et al. 2001 Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases Arterioscler Thromb Vasc Biol 21 2004 2010 11742877 10.1161/hq1201.098945 1:CAS:528:DC%2BD38XjtVOk (Pubitemid 34219754)
19. WJ Kim WH Lee 2004 LIGHT is expressed in foam cells and involved in destabilization of atherosclerotic plaques through induction of matrix metalloproteinase-9 and IL-8 Immune Netw 4 116 122
20. S Merighi A Benini P Mirandola S Gessi K Varani E Leung, et al. 2005 A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells J Biol Chem 280 19516 19526 15774470 10.1074/jbc.M413772200 1:CAS:528: DC%2BD2MXktFymsbw%3D (Pubitemid 41379472)
21. SJ You SH Lee JS Lee 2010 Kinetic analysis of RNA interference for lamin A/C in HeLa cells Acta Biochim Biophys Sin (Shanghai) 42 623 627 10.1093/abbs/gmq068 1:CAS:528:DC%2BC3cXhtV2itbvE
22. Y Teng XW Wang YW Wang J Wang 2010 Effect of siRNA-mediated beta-catenin gene on Wnt signal pathway in lung adenocarcinoma A549 cell Zhonghua Yi Xue Za Zhi 90 988 992 20646651 1:CAS:528:DC%2BC3cXhtVOrt73L
23. Z Xia Z Zhu L Zhang C Royal Z Liu Q Chen, et al. 2008 Specific reversal of MDR1/P-gp-dependent multidrug resistance by RNA interference in colon cancer cells Oncol Rep 20 1433 1439 19020725 1:CAS:528:DC%2BD1MXjs1Ghug%3D%3D
24. C Rosenau D Emery B Kaboord MW Qoronfleh 2004 Development of a high-throughput plate-based chemiluminescent transcription factor assay J Biomol Screen 9 334 342 15191650 10.1177/1087057103261446 1:CAS:528: DC%2BD2cXls1Shurs%3D
25. Y Okada Y Gonoji K Naka K Tomita I Nakanishi K Iwata, et al. 1992 Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties J Biol Chem 267 21712 21719 1400481 1:CAS:528:DyaK38XmtVOlsLw%3D
26. S Gessi V Sacchetto E Fogli S Merighi K Varani PG Baraldi, et al. 2010 Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors Biochem Pharmacol 79 1483 1495 20096265 10.1016/j.bcp.2010.01.009 1:CAS:528:DC%2BC3cXjtVCnsb4%3D
27. WJ Kim YJ Kang K Suk JE Park BS Kwon WH Lee 2008 Comparative analysis of the expression patterns of various TNFSF/TNFRSF in atherosclerotic plaques Immunol Invest 37 359 373 18569075 10.1080/08820130802123139 1:CAS:528:DC%2BD1cXnsFamu74%3D (Pubitemid 351892620)
28. F Mach U Schonbeck JY Bonnefoy JS Pober P Libby 1997 Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor Circulation 96 396 399 9244201 1:CAS:528:DyaK2sXltlShtbs%3D (Pubitemid 27329409)
29. EM Bae WJ Kim K Suk YM Kang JE Park WY Kim, et al. 2008 Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages Mol Immunol 45 523 533 17602748 10.1016/j.molimm.2007.05.013 1:CAS:528:DC%2BD2sXpslOlu7c%3D (Pubitemid 47332628)
30. E Bae WJ Kim YM Kang K Suk EM Koh HS Cha, et al. 2007 Glucocorticoid-induced tumour necrosis factor receptor-related protein-mediated macrophage stimulation may induce cellular adhesion and cytokine expression in rheumatoid arthritis Clin Exp Immunol 148 410 418 17359498 10.1111/j.1365-2249. 2007.03363.x 1:CAS:528:DC%2BD2sXnsVOnsLw%3D (Pubitemid 46701026)
31. YJ Kang WJ Kim HU Bae DI Kim YB Park JE Park, et al. 2005 Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis Cytokine 29 229 235 15760679 10.1016/j.cyto.2004.12.001 1:CAS:528:DC%2BD2MXitFequ7Y%3D (Pubitemid 40326609)
32. SH Lee EJ Kim K Suk IS Kim WH Lee 2010 TL1A induces the expression of TGF-beta-inducible gene h3 (betaig-h3) through PKC, PI3K, and ERK in THP-1 cells Cell Immunol 266 61 66 20863486 10.1016/j.cellimm.2010.08.013 1:CAS:528:DC%2BC3cXhtlenu7%2FO
33. CC Chen JK Wang 1999 p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages Mol Pharmacol 55 481 488 10051531 1:CAS:528: DyaK1MXhslWjur8%3D
34. H He MH Kogut 2003 CpG-ODN-induced nitric oxide production is mediated through clathrin-dependent endocytosis, endosomal maturation, and activation of PKC, MEK1/2 and p38 MAPK, and NF-kappaB pathways in avian macrophage cells (HD11) Cell Signal 15 911 917 12873704 10.1016/S0898-6568(03)00100-1 1:CAS:528:DC%2BD3sXlsVagsbY%3D (Pubitemid 36859802)
35. AW O'Sullivan JH Wang HP Redmond 2009 The role of P38 MAPK and PKC in BLP induced TNF-alpha release, apoptosis, and NFkappaB activation in THP-1 monocyte cells J Surg Res 151 138 144 18675993 10.1016/j.jss.2008.02.031
36. D Alvarez-Errico H Aguilar F Kitzig T Brckalo J Sayos M Lopez-Botet 2004 IREM-1 is a novel inhibitory receptor expressed by myeloid cells Eur J Immunol 34 3690 3701 15549731 10.1002/eji.200425433 1:CAS:528:DC%2BD2cXhtFajtrvL (Pubitemid 40012187)
37. L Sui N Li Q Liu W Zhang T Wan B Wang, et al. 2004 IgSF13, a novel human inhibitory receptor of the immunoglobulin superfamily, is preferentially expressed in dendritic cells and monocytes Biochem Biophys Res Commun 319 920 928 15184070 10.1016/j.bbrc.2004.05.065 1:CAS:528:DC%2BD2cXkslWms7Y%3D (Pubitemid 38739408)
38. DH Chung MB Humphrey MC Nakamura DG Ginzinger WE Seaman MR Daws 2003 CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation J Immunol 171 6541 6548 14662855 1:CAS:528:DC%2BD3sXpsV2rtrw%3D (Pubitemid 37532084)
39. D Alvarez-Errico J Sayos M Lopez-Botet 2007 The IREM-1 (CD300f) inhibitory receptor associates with the p85alpha subunit of phosphoinositide 3-kinase J Immunol 178 808 816 17202342 1:CAS:528:DC%2BD2sXhvVajsQ%3D%3D (Pubitemid 46095153)
40. C Bonny A Oberson S Negri C Sauser DF Schorderet 2001 Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death Diabetes 50 77 82 11147798 10.2337/diabetes.50.1.77 1:CAS:528:DC%2BD3MXis1Ontw%3D%3D (Pubitemid 32047984)
41. E Vives JP Richard C Rispal B Lebleu 2003 TAT peptide internalization: seeking the mechanism of entry Curr Protein Pept Sci 4 125 132 12678851 10.2174/1389203033487306 1:CAS:528:DC%2BD3sXitlSrt7g%3D (Pubitemid 36834011)